Condition
VLU
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Not Yet Recruiting2
Recruiting1
Enrolling By Invitation1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07647705Not ApplicableNot Yet Recruiting
Borate-based Bioactive Glass Fiber Matrix (BBGFM) in the Treatment of Venus Leg Ulcers (VLU)
NCT07611318Not ApplicableEnrolling By Invitation
BIO-SEE: Bioburden Imaging Outcome Study for Equivalence Evaluation
NCT07463365Phase 1Not Yet Recruiting
LUT017 Gel for Venous Leg Ulcers and Chronic Non-Healing Skin Wounds in Adults
NCT06697925Recruiting
Evaluating the Durability of Closure for Venous Leg Ulcers
Showing all 4 trials